Drug intelligence / Profile preview

paracetamol + carisoprodol + caffeine

Development stage
Preclinical
Lead developer
Wallace Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

**paracetamol + carisoprodol + caffeine** is an oral pharmaceutical combination used for the short-term management of musculoskeletal pain, muscle spasms, headaches, migraines, rheumatic pain, backache, and menstrual pain. \n- **Carisoprodol** is a centrally acting skeletal muscle relaxant that inhibits multisynaptic reflex pathways in the brain and spinal cord, leading to relief of muscle spasms.\n- **Paracetamol** (acetaminophen) is an analgesic and antipyretic that reduces pain and fever by inhibiting the synthesis of prostaglandins in the brain.\n- **Caffeine** is a methylxanthine CNS stimulant that boosts the analgesic effects of paracetamol and counteracts the sedative effect of carisoprodol, improving alertness.\nThis combination may be used for conditions including acute musculoskeletal injuries, tension headaches, and fibromyalgia. It is generally prescribed for short durations due to the habit-forming potential of carisoprodol. \nPatients should avoid additional sources of paracetamol or caffeine and consult their healthcare provider regarding safety in pregnancy, breastfeeding, and the risk of drowsiness. \nThe efficacy of this combination in fibromyalgia has also been demonstrated in clinical trials[1][2][3][5][7].

Brand names
Carisoma Compound
Other names
Somadril comp
02

Targets

ADOR (Adenosine receptors)COX

Beyond the preview

Go deeper on paracetamol + carisoprodol + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + carisoprodol + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call